| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |